Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 36 entries
Sorted by: Best Match Show Resources per page
Direct and Indirect Impact of COVID-19 for Patients with Immune-Mediated Inflammatory Diseases: A Retrospective Cohort Study.

Journal of clinical medicine

Belleudi V, Rosa AC, Poggi FR, Armuzzi A, Nicastri E, Goletti D, Diamanti AP, Davoli M, Agabiti N, Addis A.
PMID: 34071452
J Clin Med. 2021 May 28;10(11). doi: 10.3390/jcm10112388.

IMPORTANCE: Since the beginning of the Coronavirus Disease-19 (COVID-19) pandemic, Severe Acute Respiratory Syndrome-CoV-2 (SARS-CoV-2) infection has been a serious challenge for immune-compromised patients with immune-mediated inflammatory diseases (IMIDs).OBJECTIVE: Our aim was to investigate the impact of COVID-19 in...

Cite
Belleudi V, Rosa AC, Poggi FR, et al. Direct and Indirect Impact of COVID-19 for Patients with Immune-Mediated Inflammatory Diseases: A Retrospective Cohort Study. J Clin Med. 2021;10(11)doi: 10.3390/jcm10112388.
Belleudi, V., Rosa, A. C., Poggi, F. R., Armuzzi, A., Nicastri, E., Goletti, D., Diamanti, A. P., Davoli, M., Agabiti, N., & Addis, A. (2021). Direct and Indirect Impact of COVID-19 for Patients with Immune-Mediated Inflammatory Diseases: A Retrospective Cohort Study. Journal of clinical medicine, 10(11), . https://doi.org/10.3390/jcm10112388
Belleudi, Valeria, et al. "Direct and Indirect Impact of COVID-19 for Patients with Immune-Mediated Inflammatory Diseases: A Retrospective Cohort Study." Journal of clinical medicine vol. 10,11 (2021). doi: https://doi.org/10.3390/jcm10112388
Belleudi V, Rosa AC, Poggi FR, Armuzzi A, Nicastri E, Goletti D, Diamanti AP, Davoli M, Agabiti N, Addis A. Direct and Indirect Impact of COVID-19 for Patients with Immune-Mediated Inflammatory Diseases: A Retrospective Cohort Study. J Clin Med. 2021 May 28;10(11). doi: 10.3390/jcm10112388. PMID: 34071452; PMCID: PMC8197915.
Copy Download .nbib Format: NLM
Expression Profile of Fibroblast Growth Factor Receptors, Keratinocyte Differentiation Markers, and Epithelial Mesenchymal Transition-Related Genes in Actinic Keratosis: A Possible Predictive Factor for Malignant Progression?.

Biology

Persechino F, Ranieri D, Guttieri L, Nanni M, Torrisi MR, Belleudi F.
PMID: 33920760
Biology (Basel). 2021 Apr 15;10(4). doi: 10.3390/biology10040331.

Actinic keratosis (AK) is the ultra violet (UV)-induced preneoplastic skin lesion clinically classified in low (KIN I), intermediate (KIN II), and high (KIN III) grade lesions. In this work we analyzed the expression of Fibroblast Growth Factor Receptors (FGFRs),...

Cite
Persechino F, Ranieri D, Guttieri L, et al. Expression Profile of Fibroblast Growth Factor Receptors, Keratinocyte Differentiation Markers, and Epithelial Mesenchymal Transition-Related Genes in Actinic Keratosis: A Possible Predictive Factor for Malignant Progression?. Biology (Basel). 2021;10(4)doi: 10.3390/biology10040331.
Persechino, F., Ranieri, D., Guttieri, L., Nanni, M., Torrisi, M. R., & Belleudi, F. (2021). Expression Profile of Fibroblast Growth Factor Receptors, Keratinocyte Differentiation Markers, and Epithelial Mesenchymal Transition-Related Genes in Actinic Keratosis: A Possible Predictive Factor for Malignant Progression?. Biology, 10(4), . https://doi.org/10.3390/biology10040331
Persechino, Flavia, et al. "Expression Profile of Fibroblast Growth Factor Receptors, Keratinocyte Differentiation Markers, and Epithelial Mesenchymal Transition-Related Genes in Actinic Keratosis: A Possible Predictive Factor for Malignant Progression?." Biology vol. 10,4 (2021). doi: https://doi.org/10.3390/biology10040331
Persechino F, Ranieri D, Guttieri L, Nanni M, Torrisi MR, Belleudi F. Expression Profile of Fibroblast Growth Factor Receptors, Keratinocyte Differentiation Markers, and Epithelial Mesenchymal Transition-Related Genes in Actinic Keratosis: A Possible Predictive Factor for Malignant Progression?. Biology (Basel). 2021 Apr 15;10(4). doi: 10.3390/biology10040331. PMID: 33920760; PMCID: PMC8071104.
Copy Download .nbib Format: NLM
Energy Efficient Resource Allocation for M2M Devices in LTE/LTE-A.

Sensors (Basel, Switzerland)

Rekhissa HB, Belleudy C, Bessaguet P.
PMID: 31817069
Sensors (Basel). 2019 Dec 04;19(24). doi: 10.3390/s19245337.

Machine-to-machine (M2M) communication consists of the communication between intelligent devices without human intervention. Long term evolution (LTE) and Long-term evolution-advanced (LTE-A) cellular networks technologies are excellent candidates to support M2M communication as they offer high data rates, low latencies,...

Cite
Rekhissa HB, Belleudy C, Bessaguet P. Energy Efficient Resource Allocation for M2M Devices in LTE/LTE-A. Sensors (Basel). 2019;19(24)doi: 10.3390/s19245337.
Rekhissa, H. B., Belleudy, C., & Bessaguet, P. (2019). Energy Efficient Resource Allocation for M2M Devices in LTE/LTE-A. Sensors (Basel, Switzerland), 19(24), . https://doi.org/10.3390/s19245337
Rekhissa, Hajer Ben, et al. "Energy Efficient Resource Allocation for M2M Devices in LTE/LTE-A." Sensors (Basel, Switzerland) vol. 19,24 (2019). doi: https://doi.org/10.3390/s19245337
Rekhissa HB, Belleudy C, Bessaguet P. Energy Efficient Resource Allocation for M2M Devices in LTE/LTE-A. Sensors (Basel). 2019 Dec 04;19(24). doi: 10.3390/s19245337. PMID: 31817069; PMCID: PMC6960899.
Copy Download .nbib Format: NLM
The Italian Network for Monitoring Medication Use During Pregnancy (MoM-Net): Experience and Perspectives.

Frontiers in pharmacology

Belleudi V, Fortinguerra F, Poggi FR, Perna S, Bortolus R, Donati S, Clavenna A, Locatelli A, Davoli M, Addis A, Trotta F.
PMID: 34248644
Front Pharmacol. 2021 Jun 23;12:699062. doi: 10.3389/fphar.2021.699062. eCollection 2021.

There is an acute need for research to acquire high-quality information on the use of medicines in pregnancy, both in terms of appropriateness and safety. For this purpose, the Italian Medicines Agency established a Network for Monitoring Medication use...

Cite
Belleudi V, Fortinguerra F, Poggi FR, et al. The Italian Network for Monitoring Medication Use During Pregnancy (MoM-Net): Experience and Perspectives. Front Pharmacol. 2021;12:699062doi: 10.3389/fphar.2021.699062.
Belleudi, V., Fortinguerra, F., Poggi, F. R., Perna, S., Bortolus, R., Donati, S., Clavenna, A., Locatelli, A., Davoli, M., Addis, A., & Trotta, F. (2021). The Italian Network for Monitoring Medication Use During Pregnancy (MoM-Net): Experience and Perspectives. Frontiers in pharmacology, 12699062. https://doi.org/10.3389/fphar.2021.699062
Belleudi, Valeria, et al. "The Italian Network for Monitoring Medication Use During Pregnancy (MoM-Net): Experience and Perspectives." Frontiers in pharmacology vol. 12 (2021): 699062. doi: https://doi.org/10.3389/fphar.2021.699062
Belleudi V, Fortinguerra F, Poggi FR, Perna S, Bortolus R, Donati S, Clavenna A, Locatelli A, Davoli M, Addis A, Trotta F. The Italian Network for Monitoring Medication Use During Pregnancy (MoM-Net): Experience and Perspectives. Front Pharmacol. 2021 Jun 23;12:699062. doi: 10.3389/fphar.2021.699062. eCollection 2021. PMID: 34248644; PMCID: PMC8262612.
Copy Download .nbib Format: NLM
The First Dual ChE/FAAH Inhibitors: New Perspectives for Alzheimer's Disease?.

ACS medicinal chemistry letters

Rampa A, Bartolini M, Bisi A, Belluti F, Gobbi S, Andrisano V, Ligresti A, Di Marzo V.
PMID: 24900454
ACS Med Chem Lett. 2012 Jan 21;3(3):182-6. doi: 10.1021/ml200313p. eCollection 2012 Mar 08.

The treatment of Alzheimer's disease (AD) still remains an area of significant unmet need, with drugs that only target the symptoms of the disease. Therefore, there is considerable need for disease-modifying therapies. The complex etiology of AD prompts scientists...

Cite
Rampa A, Bartolini M, Bisi A, et al. The First Dual ChE/FAAH Inhibitors: New Perspectives for Alzheimer's Disease?. ACS Med Chem Lett. 2012;3(3):182-6doi: 10.1021/ml200313p.
Rampa, A., Bartolini, M., Bisi, A., Belluti, F., Gobbi, S., Andrisano, V., Ligresti, A., & Di Marzo, V. (2012). The First Dual ChE/FAAH Inhibitors: New Perspectives for Alzheimer's Disease?. ACS medicinal chemistry letters, 3(3), 182-6. https://doi.org/10.1021/ml200313p
Rampa, Angela, et al. "The First Dual ChE/FAAH Inhibitors: New Perspectives for Alzheimer's Disease?." ACS medicinal chemistry letters vol. 3,3 (2012): 182-6. doi: https://doi.org/10.1021/ml200313p
Rampa A, Bartolini M, Bisi A, Belluti F, Gobbi S, Andrisano V, Ligresti A, Di Marzo V. The First Dual ChE/FAAH Inhibitors: New Perspectives for Alzheimer's Disease?. ACS Med Chem Lett. 2012 Jan 21;3(3):182-6. doi: 10.1021/ml200313p. eCollection 2012 Mar 08. PMID: 24900454; PMCID: PMC4025825.
Copy Download .nbib Format: NLM
Improved eradication efficacy of a combination of newly identified antimicrobial agents in C. albicans and S. aureus mixed-species biofilm.

Research in microbiology

Bonvicini F, Belluti F, Bisi A, Gobbi S, Manet I, Gentilomi GA.
PMID: 34389439
Res Microbiol. 2021 Sep-Oct;172(6):103873. doi: 10.1016/j.resmic.2021.103873. Epub 2021 Aug 10.

Candida albicans and Staphylococcus aureus are common human pathogens, frequently isolated independently or co-isolated from bloodstream infections, and able to form dense polymicrobial biofilms on various medical devices resulting in strong resistance to conventionally used antimicrobials. New and innovative...

Cite
Bonvicini F, Belluti F, Bisi A, et al. Improved eradication efficacy of a combination of newly identified antimicrobial agents in C. albicans and S. aureus mixed-species biofilm. Res Microbiol. 2021;172(6):103873doi: 10.1016/j.resmic.2021.103873.
Bonvicini, F., Belluti, F., Bisi, A., Gobbi, S., Manet, I., & Gentilomi, G. A. (2021). Improved eradication efficacy of a combination of newly identified antimicrobial agents in C. albicans and S. aureus mixed-species biofilm. Research in microbiology, 172(6), 103873. https://doi.org/10.1016/j.resmic.2021.103873
Bonvicini, Francesca, et al. "Improved eradication efficacy of a combination of newly identified antimicrobial agents in C. albicans and S. aureus mixed-species biofilm." Research in microbiology vol. 172,6 (2021): 103873. doi: https://doi.org/10.1016/j.resmic.2021.103873
Bonvicini F, Belluti F, Bisi A, Gobbi S, Manet I, Gentilomi GA. Improved eradication efficacy of a combination of newly identified antimicrobial agents in C. albicans and S. aureus mixed-species biofilm. Res Microbiol. 2021 Sep-Oct;172(6):103873. doi: 10.1016/j.resmic.2021.103873. Epub 2021 Aug 10. PMID: 34389439.
Copy Download .nbib Format: NLM
[Greatness and decline of the School of Salerno].

La Riforma medica

BELLELLI F.
PMID: 13798540
Riforma Med. 1960 May 21;74:591-4.

No abstract available.

Cite
BELLELLI F. [Greatness and decline of the School of Salerno]. Riforma Med. 1960;74:591-4
BELLELLI, F. (1960). [Greatness and decline of the School of Salerno]. La Riforma medica, 74591-4.
BELLELLI, F. "[Greatness and decline of the School of Salerno]." La Riforma medica vol. 74 (1960): 591-4.
BELLELLI F. [Greatness and decline of the School of Salerno]. Riforma Med. 1960 May 21;74:591-4. Italian. PMID: 13798540.
Copy Download .nbib Format: NLM
On-chip detection of non-classical light by scalable integration of single-photon detectors.

Nature communications

Najafi F, Mower J, Harris NC, Bellei F, Dane A, Lee C, Hu X, Kharel P, Marsili F, Assefa S, Berggren KK, Englund D.
PMID: 25575346
Nat Commun. 2015 Jan 09;6:5873. doi: 10.1038/ncomms6873.

Photonic-integrated circuits have emerged as a scalable platform for complex quantum systems. A central goal is to integrate single-photon detectors to reduce optical losses, latency and wiring complexity associated with off-chip detectors. Superconducting nanowire single-photon detectors (SNSPDs) are particularly...

Cite
Najafi F, Mower J, Harris NC, et al. On-chip detection of non-classical light by scalable integration of single-photon detectors. Nat Commun. 2015;6:5873doi: 10.1038/ncomms6873.
Najafi, F., Mower, J., Harris, N. C., Bellei, F., Dane, A., Lee, C., Hu, X., Kharel, P., Marsili, F., Assefa, S., Berggren, K. K., & Englund, D. (2015). On-chip detection of non-classical light by scalable integration of single-photon detectors. Nature communications, 65873. https://doi.org/10.1038/ncomms6873
Najafi, Faraz, et al. "On-chip detection of non-classical light by scalable integration of single-photon detectors." Nature communications vol. 6 (2015): 5873. doi: https://doi.org/10.1038/ncomms6873
Najafi F, Mower J, Harris NC, Bellei F, Dane A, Lee C, Hu X, Kharel P, Marsili F, Assefa S, Berggren KK, Englund D. On-chip detection of non-classical light by scalable integration of single-photon detectors. Nat Commun. 2015 Jan 09;6:5873. doi: 10.1038/ncomms6873. PMID: 25575346; PMCID: PMC4354051.
Copy Download .nbib Format: NLM
Role of FGFR2c and Its PKC.

Cancers

Ranieri D, Guttieri L, Raffa S, Torrisi MR, Belleudi F.
PMID: 34638477
Cancers (Basel). 2021 Oct 05;13(19). doi: 10.3390/cancers13194993.

Pancreatic ductal adenocarcinoma (PDAC) is a treatment-resistant malignancy characterized by a high malignant phenotype including acquired EMT signature and deregulated autophagy. Since we have previously described that the aberrant expression of the mesenchymal FGFR2c and the triggering of the...

Cite
Ranieri D, Guttieri L, Raffa S, et al. Role of FGFR2c and Its PKC. Cancers (Basel). 2021;13(19)doi: 10.3390/cancers13194993.
Ranieri, D., Guttieri, L., Raffa, S., Torrisi, M. R., & Belleudi, F. (2021). Role of FGFR2c and Its PKC. Cancers, 13(19), . https://doi.org/10.3390/cancers13194993
Ranieri, Danilo, et al. "Role of FGFR2c and Its PKC." Cancers vol. 13,19 (2021). doi: https://doi.org/10.3390/cancers13194993
Ranieri D, Guttieri L, Raffa S, Torrisi MR, Belleudi F. Role of FGFR2c and Its PKC. Cancers (Basel). 2021 Oct 05;13(19). doi: 10.3390/cancers13194993. PMID: 34638477; PMCID: PMC8508074.
Copy Download .nbib Format: NLM
Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014.

Frontiers in endocrinology

Marcianò I, Ingrasciotta Y, Giorgianni F, Ientile V, Chinellato A, Tari DU, Gini R, Cannavò S, Pastorello M, Scondotto S, Cananzi P, Traversa G, Trotta F, Belleudi V, Addis A, Trifirò G.
PMID: 29593655
Front Endocrinol (Lausanne). 2018 Mar 13;9:95. doi: 10.3389/fendo.2018.00095. eCollection 2018.

PURPOSE: Somatropin [recombinant growth hormone (rGH)] is approved in children and adults for several conditions involving growth disturbances and the corresponding biosimilar is available in Italy since 2006. No population-based data are available on the pattern of rGH use...

Cite
Marcianò I, Ingrasciotta Y, Giorgianni F, et al. Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014. Front Endocrinol (Lausanne). 2018;9:95doi: 10.3389/fendo.2018.00095.
Marcianò, I., Ingrasciotta, Y., Giorgianni, F., Ientile, V., Chinellato, A., Tari, D. U., Gini, R., Cannavò, S., Pastorello, M., Scondotto, S., Cananzi, P., Traversa, G., Trotta, F., Belleudi, V., Addis, A., & Trifirò, G. (2018). Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014. Frontiers in endocrinology, 995. https://doi.org/10.3389/fendo.2018.00095
Marcianò, Ilaria, et al. "Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014." Frontiers in endocrinology vol. 9 (2018): 95. doi: https://doi.org/10.3389/fendo.2018.00095
Marcianò I, Ingrasciotta Y, Giorgianni F, Ientile V, Chinellato A, Tari DU, Gini R, Cannavò S, Pastorello M, Scondotto S, Cananzi P, Traversa G, Trotta F, Belleudi V, Addis A, Trifirò G. Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014. Front Endocrinol (Lausanne). 2018 Mar 13;9:95. doi: 10.3389/fendo.2018.00095. eCollection 2018. PMID: 29593655; PMCID: PMC5859012.
Copy Download .nbib Format: NLM
Correction of an adult Class II division 2 individual using fixed functional appliance: A noncompliance approach.

Contemporary clinical dentistry

Basavaraddi S, Gandedkar NH, Belludi A, Patil A.
PMID: 27041908
Contemp Clin Dent. 2016 Jan-Mar;7(1):82-6. doi: 10.4103/0976-237X.177114.

This case report describes the application of fixed functional appliance in the treatment of an adult female having Class II division 2 malocclusion with retroclination of upper incisors. Fixed functional appliance was used to correct the overjet after the...

Cite
Basavaraddi S, Gandedkar NH, Belludi A, et al. Correction of an adult Class II division 2 individual using fixed functional appliance: A noncompliance approach. Contemp Clin Dent. 2016;7(1):82-6doi: 10.4103/0976-237X.177114.
Basavaraddi, S., Gandedkar, N. H., Belludi, A., & Patil, A. (2016). Correction of an adult Class II division 2 individual using fixed functional appliance: A noncompliance approach. Contemporary clinical dentistry, 7(1), 82-6. https://doi.org/10.4103/0976-237X.177114
Basavaraddi, Shrinivas, et al. "Correction of an adult Class II division 2 individual using fixed functional appliance: A noncompliance approach." Contemporary clinical dentistry vol. 7,1 (2016): 82-6. doi: https://doi.org/10.4103/0976-237X.177114
Basavaraddi S, Gandedkar NH, Belludi A, Patil A. Correction of an adult Class II division 2 individual using fixed functional appliance: A noncompliance approach. Contemp Clin Dent. 2016 Jan-Mar;7(1):82-6. doi: 10.4103/0976-237X.177114. PMID: 27041908; PMCID: PMC4792063.
Copy Download .nbib Format: NLM
Medication prescriptions before, during and after pregnancy in Italy: a population-based study.

Annali dell'Istituto superiore di sanita

Fortinguerra F, Belleudi V, Poggi FR, Bortolus R, Puccini A, Solfrini V, Stella P, Trotta F.
PMID: 34554120
Ann Ist Super Sanita. 2021 Jul-Sep;57(3):249-258. doi: 10.4415/ANN_21_03_09.

BACKGROUND: Monitoring medicine prescriptions in pregnancy is an aspect of extreme interest in term of public health.METHODS: A retrospective prevalence study using administrative healthcare databases was performed in order to evaluate medication prescriptions in Italy. A cohort of 274,938...

Cite
Fortinguerra F, Belleudi V, Poggi FR, et al. Medication prescriptions before, during and after pregnancy in Italy: a population-based study. Ann Ist Super Sanita. 2021;57(3):249-258doi: 10.4415/ANN_21_03_09.
Fortinguerra, F., Belleudi, V., Poggi, F. R., Bortolus, R., Puccini, A., Solfrini, V., Stella, P., & Trotta, F. (2021). Medication prescriptions before, during and after pregnancy in Italy: a population-based study. Annali dell'Istituto superiore di sanita, 57(3), 249-258. https://doi.org/10.4415/ANN_21_03_09
Fortinguerra, Filomena, et al. "Medication prescriptions before, during and after pregnancy in Italy: a population-based study." Annali dell'Istituto superiore di sanita vol. 57,3 (2021): 249-258. doi: https://doi.org/10.4415/ANN_21_03_09
Fortinguerra F, Belleudi V, Poggi FR, Bortolus R, Puccini A, Solfrini V, Stella P, Trotta F. Medication prescriptions before, during and after pregnancy in Italy: a population-based study. Ann Ist Super Sanita. 2021 Jul-Sep;57(3):249-258. doi: 10.4415/ANN_21_03_09. PMID: 34554120.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 36 entries